Ticker Details
Avanos Medical, Inc.
IPO Date:	October 20, 2014
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$655.29M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 1.60%
Avg Daily Range (30 D):	$0.14 | 1.04%
Avg Daily Range (90 D):	$0.20 | 1.51%

Institutional Daily Volume
Avg Daily Volume:	.27M
Avg Daily Volume (30 D):	.41M
Avg Daily Volume (90 D):	.41M

Trade Size
Avg Trade Size (Sh.):	61
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	53

Institutional Trades
Total Institutional Trades:	2,789
Avg Institutional Trade:	$1.55M
Avg Institutional Trade (30 D):	$1.38M
Avg Institutional Trade (90 D):	$1.26M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.53M
Avg Closing Trade (30 D):	$1.47M
Avg Closing Trade (90 D):	$1.3M
Avg Closing Volume:	58.22K

News

Aug 5, 2025 @ 2:14 PM Avanos (AVNS) Q2 2025 Earnings Call Transcript Source: The Motley Fool

Dec 30, 2024 @ 12:58 PM United States Syringes, Needles and Urinary Cathet... Source: Researchandmarkets.Com

Oct 6, 2024 @ 11:30 PM Bio Pharma Buffer Market to Reach $2.4 Billion, Gl... Source: Allied Market Research

Aug 29, 2024 @ 12:17 PM Pain Management Devices Market to Witness 21.5 % C... Source: Globe Newswire

Aug 5, 2024 @ 11:52 AM Is Phibro (PAHC) Stock Worth Retaining in Your Por... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-10.19	$-.03	$-1.66
Diluted EPS	$-10.19	$-.03	$-1.66
Revenue	$699.9M	$177.8M	$175M
Gross Profit	$365.9M	$86M	$92.1M
Net Income / Loss	$-468.9M	$-1.4M	$-76.8M
Operating Income / Loss	$-482.6M	$.1M	$-74.5M
Cost of Revenue	$334M	$91.8M	$82.9M
Net Cash Flow	$-18.5M	$-19.8M	$-6.7M
PE Ratio

Splits
May 15, 2006	1:100